Whats New Out There
- Sort by:
- Date
- Alphabetical Order
A note of caution when taking calcium supplements with vitamin D
A case report published in Archives of Neurology shows the potential risk associated with taking calcium supplements with vitamin D Read more >Belgian review article outlines vascular abnormalities in MS
A new review published in Lancet Neurology outlines the various vascular abnormalities that are associated with MS, but finds little evidence of a causative role for CCSVI Read more >Does exercise affect MS progression?
Danish researchers examine the important question of whether exercise affects the progression of multiple sclerosis, and find plenty of evidence to support this contention Read more >Early disclosure of MS diagnosis to people by their doctors improves quality of life and psychological wellbeing
While some doctors in the past have opted not to tell people they have MS after diagnosis, new research indicates early disclosure is better Read more >Editorial questions why we have no studies on high dose vitamin D preventing MS
A prominent Irish neurologist writing in the major international journal Multiple Sclerosis has queried why we have lots of drug company funded studies on MS drugs but none on preventing MS with high dose vitamin D. Read more >Endocrine Society Taskforce publishes new guidelines for vitamin D supplementation
After the Institute of Medicine's alarmist suggestions limiting the upper limit of vitamin D supplementation to 4,000IU a day, this new Clinical Practice Guideline for endocrinologists provides far more reasonable evidence-based recommendations Read more >For those who have never read Swank's paper in the Lancet
Many people make comment about Swank's study without ever having read the paper; here is the full paper as published in the Lancet in 1990 Read more >Immunisations not associated with increased MS risk
After several smaller studies suggesting some increased risk of developing MS with some vaccines, a recent meta-analysis has shown that none of the commonly used vaccines raises risk, and some lower it. Read more >Is there a rebound of disease activity after stopping Tysabri, or is it just a return to baseline level activity?
The experts are arguing about what happens when you stop Tysabri: does the disease just revert to what it was doing before you started, or is there a rebound effect? Read more >Lancet Neurology rounds up advances in MS in 2011
Lancet Neurology summarises the recent developments in MS for 2011 Read more >